Blocking the anoxic depolarization protects without functional compromise following simulated stroke in cortical

Trent R Anderson1, Cathryn R Jarvis, Alyson J Biedermann

  • 1Department of Anatomy and Cell Biology, Queen's University, Kingston, Ontario, Canada.

Insights

Sigma-1 receptor ligands effectively block anoxic depolarization (AD), a rapid neuronal injury during stroke. This neuroprotective strategy preserves neuronal function and improves recovery by targeting the underlying conductance.

Area of Science:

  • Neuroscience
  • Stroke research
  • Cellular physiology

Background:

  • Anoxic depolarization (AD) causes acute neuronal injury during stroke due to ion pump failure.
  • Existing blockers targeting neurotransmitter receptors are ineffective against AD.
  • Identifying AD blockers that preserve neuronal function is crucial for neuroprotection.

Purpose of the Study:

  • To identify novel blockers of anoxic depolarization (AD).
  • To investigate the neuroprotective potential of sigma-1 receptor ligands against acute neuronal injury during stroke.
  • To understand the properties of the conductance underlying AD.

Main Methods:

  • Utilized live brain slices (neocortical and hippocampal) to image AD onset and propagation via light transmittance.
  • Tested sigma-1 receptor ligands for their ability to block AD.
  • Recorded evoked field potentials and axonal conduction to assess neuronal function post-treatment.

Main Results:

  • Sigma-1 receptor ligands, at 10-30 microM, successfully blocked AD in pretreated brain slices.
  • Ligand treatment prevented cell swelling, dendritic damage, and loss of evoked potentials.
  • Delaying AD onset significantly improved electrophysiological recovery, with intact axonal conduction and synaptic transmission.

Conclusions:

  • Sigma-1 receptor ligands are effective blockers of anoxic depolarization, offering a promising neuroprotective strategy for stroke.
  • These ligands help elucidate the properties of the conductance responsible for AD, a key target for acute stroke therapies.
  • Targeting the upstream conductance of AD is vital for mitigating early neuronal damage in stroke.